ClinicalTrials.Veeva

Menu

Exploring Mechanisms for Neuropsychiatric Symptoms of Parkinson Disease Using Transcranial Direct Current Stimulation

Johns Hopkins University logo

Johns Hopkins University

Status

Suspended

Conditions

Idiopathic Parkinson's Disease
Parkinson Disease
Depression

Treatments

Device: Transcranial Direct Current Stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT03074812
IRB00087957

Details and patient eligibility

About

This study evaluates the effect of transcranial direct current stimulation (tDCS) on non-motor symptoms of Parkinson's disease, including depression and cognitive symptoms. Participants are randomized to receive active or sham tDCS for 30 minutes over 10 treatment sessions.

Enrollment

80 estimated patients

Sex

All

Ages

18 to 95 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Abel to provide written informed consent is obtained in the English language
  • Age 18 to 95 years old
  • Movement Disorder Society Clinical Diagnostic Criteria for probable idiopathic Parkinson disease
  • Report disabling depressive or neuropsychiatric symptoms prior to study entry
  • Capacity to understand the nature of the study;

Exclusion criteria

  • Known structural brain disease such as a neoplasm, abscess etc.
  • Pre-existing skull / scalp defects that would impede standardized electrode placement
  • Current electronic or metal implants
  • Diagnosis of Bipolar Disorder, Post-Traumatic Stress Disorder, a Psychotic Disorder or any other non-unipolar depressive disorder as a principal diagnosis in the 6 months prior to screening;
  • Concurrent treatment with medication which may affect tDCS (benzodiazepines, anticonvulsants, dextromethorphan and pseudoephedrine)
  • Endorse active suicidal ideation at enrollment or during any study visit, or have attempted suicide in the six months prior to screening;
  • History of substance abuse or dependence in the 2 months prior to screening;
  • Considered to be at significant risk of committing homicide;
  • Unstable medical condition;
  • Score less than 22 on the Montreal Cognitive Assessment (MoCA)
  • Women of childbearing potential who are pregnant or are considering becoming pregnant during the length of the study;
  • There has been a change in their depression or psychotherapy treatment regimen in the 2 weeks preceding screening;

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

80 participants in 2 patient groups

Sham tDCS
Sham Comparator group
Description:
Sham transcranial direct current stimulation where current will be reduced to zero after standardized ramp up to 2 mA
Treatment:
Device: Transcranial Direct Current Stimulation
Active tDCS
Experimental group
Description:
Transcranial direct current stimulation according to protocol maintained for 30 minutes after ramping up to 2 mA
Treatment:
Device: Transcranial Direct Current Stimulation

Trial contacts and locations

1

Loading...

Central trial contact

Yousef Salimpour, Ph.D.; Kelly Mills, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems